Adial Pharmaceuticals, Inc. (ADIL)
6.36
-0.29
(-4.36%)
USD |
NASDAQ |
Sep 09, 09:56
Adial Pharmaceuticals Total Assets (Quarterly) : 29.09M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 29.09M |
| March 31, 2026 | 5.227M |
| December 31, 2025 | 6.798M |
| September 30, 2025 | 5.660M |
| June 30, 2025 | 6.802M |
| March 31, 2025 | 3.451M |
| December 31, 2024 | 5.082M |
| September 30, 2024 | 6.713M |
| June 30, 2024 | 4.949M |
| March 31, 2024 | 6.684M |
| December 31, 2023 | 4.737M |
| September 30, 2023 | 2.867M |
| June 30, 2023 | 3.779M |
| March 31, 2023 | 3.902M |
| December 31, 2022 | 5.733M |
| September 30, 2022 | 7.742M |
| June 30, 2022 | 10.92M |
| March 31, 2022 | 13.96M |
| December 31, 2021 | 7.634M |
| September 30, 2021 | 10.45M |
| Date | Value |
|---|---|
| June 30, 2021 | 8.063M |
| March 31, 2021 | 8.626M |
| December 31, 2020 | 5.491M |
| September 30, 2020 | 8.178M |
| June 30, 2020 | 9.475M |
| March 31, 2020 | 5.941M |
| December 31, 2019 | 7.680M |
| September 30, 2019 | 9.507M |
| June 30, 2019 | 10.69M |
| March 31, 2019 | 12.06M |
| December 31, 2018 | 4.699M |
| September 30, 2018 | 5.252M |
| June 30, 2018 | 0.1871M |
| March 31, 2018 | 0.0801M |
| December 31, 2017 | 0.0345M |
| September 30, 2017 | 0.0788M |
| June 30, 2017 | 0.1957M |
| March 31, 2017 | 0.0859M |
| December 31, 2016 | 0.1515M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 142.28B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 67.47M |
| Shareholders Equity (Quarterly) | -38.38M |
| Debt to Equity Ratio | -1.624 |
| Current Ratio | 5.633 |
| Net Debt Paydown Yield | -185.5% |